Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Neuronal Signaling|August 21, 2023
Modeling Parkinson's disease in LRRK2 rodentsChiara Domenicale, Stefano Magnabosco, Michele MorariBiochemical Society Transactions|February 28, 2022
Modeling Parkinson's disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathwayFederica Albanese, Chiara Domenicale, Mattia Volta, et al.Scientific Reports|March 23, 2025
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2Federica Albanese, Chiara Domenicale, Daniela Mercatelli, et al.Biomedicines|April 23, 2022
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out MiceChiara Domenicale, Daniela Mercatelli, Federica Albanese, et al.The Analyst|January 14, 2015
Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's diseaseMichele Morari, Martina FantinBrain : a Journal of Neurology|October 1, 2024
Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonismMaria Regoni, Letizia Zanetti, Martina Sevegnani, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 25, 2011
Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in ratsRiccardo Viaro, Michele Morari, Gianfranco FranchiJournal of Neurochemistry|November 19, 2008
The novel nociceptin/orphanin FQ receptor antagonist Trap-101 alleviates experimental parkinsonism through inhibition of the nigro-thalamic pathway: positive interaction with L-DOPAMatteo Marti, Claudio Trapella, Michele MorariJournal of Neurochemistry|July 12, 2011
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levelsSimone Bido, Matteo Marti, Michele MorariExperimental Neurology|February 4, 2010
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockadeRiccardo Viaro, Matteo Marti, Michele MorariPageof 10